logo
episode-header-image
Aug 2024
26m 32s

Ecstasy Therapy: Bad trip

Vox
About this episode
A clinical trial for MDMA-assisted therapy showed promising results. But participants who say they suffered afterward allege their experiences aren’t reflected in the data. This episode was reported and produced by Haleema Shah, engineered by Andrea Kristinsdottir and Rob Byers, and hosted by Sean Rameswaram. It was edited by Lissa Soep and Matt Collette, wh ... Show More
Up next
Yesterday
Susan Collins, political ninja
The Maine senator has dodged decades of attacks, but President Trump’s low approval ratings could be her political deathblow. This episode was produced by Avishay Artsy and Dustin DeSoto, edited by Amina Al-Sadi, fact-checked by Gabriel Dunatov, engineered by David Tatasciore and ... Show More
25m 39s
Oct 18
The quest for the perfect baby
Men and women are trying to maximize their reproductive health due to anxieties around declining fertility trends. But are we taking “embryomaxxing” too far? This episode was produced by Miles Bryan, edited by Avishay Artsy, fact-checked by Melissa Hirsch, engineered by David Tat ... Show More
30m 23s
Oct 17
Can you buy the midterms?
Republicans are entering the midterm home stretch with a staggering $1 billion campaign war chest. Will it make a difference? This show was edited by Kasia Broussalian, fact checked by Esther Gim, mixed by Vasilis Fotopoulos, video edited by Christopher Snyder, and hosted by Aste ... Show More
35m 41s
Recommended Episodes
Aug 2024
Ecstasy therapy
The FDA is about to announce whether it’s going to approve MDMA as a treatment for PTSD. Our friends at Today, Explained explore what this kind of therapy looks like, and why it’s so controversial. For show transcripts, go to vox.com/unxtranscripts For more, go to vox.com/unexpla ... Show More
30m 18s
Jul 2023
The therapeutic potential of MDMA
In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ... Show More
47m 52s
May 2024
The Power and Promise of Psychedelics in Therapy
Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls ... Show More
38m 24s
Jul 2025
Promising new results from psychedelic clinical trials
Send us Fan MailThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DM ... Show More
38m 13s
Feb 2023
The Promise and Perils of Psychedelics
In this episode of “Intention to Treat,” a study participant and a long-time investigator of hallucinogenic drugs for psychiatric conditions illuminate the effects of psilocybin in patients with depression. A full transcript of this episode is available at https://www.nejm.org/do ... Show More
30m 8s
Oct 2024
Are psychedelics breaking science?
Drugs like ecstasy and mushrooms have shown promise as mental health treatments, but they’re also exposing some major cracks in how scientists study the brain. Guests: Jonathan Lambert, science journalist; Boris Heifets, professor at Stanford University of Medicine; Amy Mcguire, ... Show More
24m 40s